-
Co-founder of Azevan Pharmaceuticals featured in Keystone Edge
Azevan Pharmaceuticals is currently in Phase Two of clinical trials for a drug that its founders hope will help patients with mood disorders, including intermittent explosive disorder and PTSD. Read more: http://bit.ly/1uKgfie